ES2406107T3 - Compuestos antitumorales - Google Patents

Compuestos antitumorales Download PDF

Info

Publication number
ES2406107T3
ES2406107T3 ES08861840T ES08861840T ES2406107T3 ES 2406107 T3 ES2406107 T3 ES 2406107T3 ES 08861840 T ES08861840 T ES 08861840T ES 08861840 T ES08861840 T ES 08861840T ES 2406107 T3 ES2406107 T3 ES 2406107T3
Authority
ES
Spain
Prior art keywords
substituted
unsubstituted
group
alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08861840T
Other languages
English (en)
Spanish (es)
Inventor
Judit Tulla-Puche
Eleonora Marcucci
Núria BAYÓ-PUXAN
Fernando Albericio
María del Carmen CUEVAS MARCHANTE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Application granted granted Critical
Publication of ES2406107T3 publication Critical patent/ES2406107T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES08861840T 2007-12-14 2008-12-10 Compuestos antitumorales Active ES2406107T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07380361 2007-12-14
EP07380361 2007-12-14
PCT/EP2008/067189 WO2009077401A1 (en) 2007-12-14 2008-12-10 Antitumoral compounds

Publications (1)

Publication Number Publication Date
ES2406107T3 true ES2406107T3 (es) 2013-06-05

Family

ID=40290734

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08861840T Active ES2406107T3 (es) 2007-12-14 2008-12-10 Compuestos antitumorales

Country Status (8)

Country Link
US (1) US8748388B2 (enExample)
EP (1) EP2231695B1 (enExample)
JP (1) JP5577256B2 (enExample)
CN (1) CN101932592B (enExample)
AU (1) AU2008337605B2 (enExample)
CA (1) CA2708080C (enExample)
ES (1) ES2406107T3 (enExample)
WO (1) WO2009077401A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110027417A1 (en) 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
US10370409B2 (en) * 2011-10-25 2019-08-06 The Scripps Research Institute Synthesis of libraries of peptide tertiary amides
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN111777668B (zh) * 2020-07-28 2022-02-25 安徽工程大学 一种基于海洋环肽Samoamide A的改造多肽、合成方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681813A (en) * 1994-04-06 1997-10-28 Pharma Mar, S.A. Thiodepsipeptide isolated from a marine actinomycete
KR20030088423A (ko) * 2000-12-21 2003-11-19 더 스크립스 리서치 인스티튜트 티오코르알린 및 be-22179의 동족체

Also Published As

Publication number Publication date
CN101932592A (zh) 2010-12-29
JP2011506393A (ja) 2011-03-03
US8748388B2 (en) 2014-06-10
WO2009077401A1 (en) 2009-06-25
JP5577256B2 (ja) 2014-08-20
AU2008337605B2 (en) 2013-08-29
US20110207674A2 (en) 2011-08-25
CA2708080A1 (en) 2009-06-25
EP2231695B1 (en) 2013-02-13
HK1149022A1 (en) 2011-09-23
CA2708080C (en) 2016-06-14
AU2008337605A1 (en) 2009-06-25
CN101932592B (zh) 2014-02-26
EP2231695A1 (en) 2010-09-29
US20100292163A1 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
ES2944579T3 (es) Compuestos antitumorales
ES2406107T3 (es) Compuestos antitumorales
HK1149022B (en) Antitumoral compounds
HK40069341B (en) Antitumoral compounds
EA048329B1 (ru) Противоопухолевые соединения
EA048344B1 (ru) Противоопухолевые соединения
HK40023315B (en) Antitumoral compounds
HK40023315A (en) Antitumoral compounds
EA048007B1 (ru) Противоопухолевые соединения